Growth hormone response to sumatriptan (5-HT1D agonist) challenge in seasonal affective disorder: Effects of light therapy

Biological Psychiatry

Volumn 42, Issue 1, 1997, Pages 24-29

  Yatham, Lakshmi N ^a   Lam, Raymond W ^a   Zis, Athanasios P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

5 HT1D receptors; Growth hormone; Seasonal affective disorder; Serotonin; Sumatriptan

Indexed keywords

GROWTH HORMONE; SEROTONIN 1 AGONIST; SEROTONIN 1D RECEPTOR; SUMATRIPTAN;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; GROWTH HORMONE RELEASE; HAMILTON SCALE; HUMAN; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; SEASONAL VARIATION; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION; WINTER;

ADULT; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PHOTOTHERAPY; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, SEROTONIN; SEASONAL AFFECTIVE DISORDER; SEROTONIN AGONISTS; SUMATRIPTAN; TREATMENT OUTCOME;

EID: 0030874189     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00243-0     Document Type: Article

References (33)

1. American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental Disorders 4th Edition; Washington DC.
2. Azuma H, Yamatodani A, Yagi A, Nishimura R, Wada H (1991): Effect of bright light in the morning on diurnal variations of pineal indoles in NZBWF1 mice. Neurosci Lett 131:210-212.
3. Brownstein M, Arimura A, Sato H, Schally AV, Kizer JS (1975): The regional distribution of somatostatin in the rat brain. Endocrinology 96:1456.
4. Cagampang FR, Yamazaki S, Otori Y, Inouye SI (1993): Serotonin in the raphae nuclei: regulation by light and an endogenous pacemaker. Neuroreport 5:49-52.
5. Chihara K, Arimura A, Schally AV (1979): Effect of intraventricular injection of dopamine, norepinephrine, acetylcholine, and 5-hydroxytryptamine on immunoreactive somatostatin release into rat hypophyseal portal blood. Endocrinology 104:1656-1662.
6. Coiro V, Volpi R, Marchesi C, De Ferri A, Davoli C, Caffarra P, Rossi G, Caffarri G, Davolio M, Chiodera P (1993): Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorder. Psychoneuroendocrinology 18:551-556.
7. Foote WE, Taber-Pierce E, Edwards L (1978): Evidence for a retinal projection to the midbrain raphe of the cat. Brain Res 156:135-140.
8. Fowler PA, Lacey LF, Thomas M, Keene ON, Tanner RJN, Baber NS (1991): The clinical pharmacology, pharmacokinetics and metabolism of Sumatriptan. Eur Neurol 31:291-294.
9. Fraikin GY, Strakhovskaya MG, Ivanova EV, Rubin AB (1989): Near-UV activation of enzymatic conversion of 5-hydroxy-tryptophan to serotonin. Photochem Photobiol 49:475-477.
10. Franceschini R, Cataldi A, Garibaldi P, Scordamaglia A, Barreca T, Rolandi E (1994): The effects of sumatriptan on pituitary secretion in man. Neuropharmacology 33:235-239.
11. Frohman LA, Downs TR, Chomczynski P (1992): Regulation of growth hormone secretion. Front Neuroendocrinol 13:344-405.
12. Garcia-Borreguero D, Jacobsen FM, Murphy DL, Joseph-Vanderpool JR, Chiara A, Rosenthal NE (1995): Hormonal responses to the administration of m-Chlorophenylpiperazine in patients with seasonal affective disorder and controls. Biol Psychiatry 37:740-749.
13. Humphrey PPA, Feniuk W, Marriott AS, Tanner RJN, Jackson MR, Tucker ML (1991): Preclinical studies on the antimigraine drug, Sumpatriptan. Eur Neurol 31:282-290.
14. Jacobsen FM, Sack DA, Wehr TA, Rogers S, Rosenthal NE (1987): Neuroendocrine response to 5 hydroxytryptophan in seasonal affective disorder. Arch Gen Psychiatry 44:1086-1091.
15. Joseph-Vanderpool JR, Jacobsen FM, Murphy DL, Hill JL, Rosenthal NE (1993): Seasonal variation in behavioural responses to m-CPP in patients with seasonal affective disorder and controls. Biol Psychiatry 33:496-504.
16. Kato Y, Matsushita N, Katkami H, Imura H (1980): Brain serotonin and the secretion of prolactin and growth hormone. Clin Endocrinol (Tokyo) 28:625.
17. Knigge KM, Silverman AJ (1972): Transport capacity of the median eminence, In Knigge KM, Scott DE, Weindl A (eds), Brain-Endocrine Interaction: Median Eminence: Structure and Function. Basel: Karger, p 350.
18. Lam RW, Grewal A, Zis AP, Delgado PL, Charney DS, Krystal JH (1994): Effects of rapid tryptophan depletion in remitted seasonal affective disorder patients after light therapy. Presented at The American College of Neuropsychopharmacology 33rd Annual Meeting, San Juan, Puerto Rico.
19. Mason R (1986): Circadian variation in sensitivity of suprachiasmatic and lateral geniculate neurones to 5-hydroxytryptamine in the rat. J Physiol 377:1-13.
20. McNulty JA, Prechel MM, Simmons WH (1986): Correlations of serotonin and its metabolites in individual rat pineal glands over light dark cycles and after acute light exposure. Life Sci 39:1-6.
21. Murakami Y, Kato Y, Kabayama Y, Tojo K, Inque T, Imura H (1986): Involvement of Growth hormone (GH)-releasing factor in GH secretion induced by serotoninergic mechanisms in conscious rats. Endocrinology 119(3): 1089-1092.
22. 2+ response, and 5-HT content in winter seasonal affective disorder. Biol Psychiatry 36:458-466.
23. Peroutka SJ, McCarthy BG (1989): Sumatriptan (GR43175) interacts selectively with 5-HT1B and 5-HT1D binding sites. Eur J Pharmacol 163:133-6.
24. Rosen LN, Targum SD, Terman M, Bryant MJ, Hoffman H, Kasper SF, Hamovit JR, Docherty JP, Welch B, Rosenthal NE (1990): Prevalence of seasonal affective disorder at four latitudes. Psychiatry Res 31:131-144.
25. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, Mueller PS, Newsome DA, Wehr TA (1984): Seasonal affective disorder: A description of syndrome and preliminary findings with light treatment. Arch Gen Psychiatry 41:72-80.
26. Rosenthal NE, Schwartx PJ, Leibenluft E, Peeke P, Turner EH, Oren DA, Gold PW, Wehr TA (1995): Evidence for hypothalamic disturbance in seasonal affective disorder. Abstract, Society for Light Treatment and Biological Rhythms, 7th Annual Meeting, pp 7, Frankfurt: Germany.
27. Sawchenko PE, Swanson LW, Rivier J, Valer WW (1985): The distribution of growth-hormone-releasing factor (GRF) immunoreactivity in the central nervous system of the rat. An immunohistochemistry study using antisera directed against rat hypothalamic GRF. J Comp Neural, 237:100-115.
28. Schoeffter P, Hoyer D (1989): How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors. Naunyn Schmiedeberg's Archs Pharmacol 340:135-138.
29. Sleight AJ, Cervenka A, Peroutka SJ (1990): In vivo effects of sumatriptan (GR43175) on extracellular levels of 5-HT in the guinea pig. Neuropharmacology 29:511-513.
30. Szadoczky E, Falus A, Nemeth A, Teszeri G, Moussong-Kovacs E (1991): Effect of phototherapy on 3H-imipramine binding sites in patients with SAD, non-SAD and in healthy controls. J Affect Disord 22:179-184.
31. Terman M, Terman JS, Quitkin FM, McGrath PJ, Stewart JW, Rafferty B (1989): Light therapy for seasonal affective disorder. A review of efficacy. Neuropsychopharmacology 2:1-22.
32. Urman S, Kaler L, Critchlow V (1985): Effects of hypothalamic periventricular lesions on pulsatile growth hormone secretion. Neuroendocrinology, 41:357-362.
33. Vance ML, Kaiser DL, Evans WS, Thorner MO, Furlanetto R, Rivier J, Vale W, Perisutti G, Frohman LA (1985): Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man. J Clin Endocrinol Metab 60:370-375.